Key result
First-in-human extraction of a Micra transcatheter pacing system is reported.
Why the study?
Clinical trials investigating the safety and effectiveness of transcatheter leadless pacemakers in humans are ongoing.
This paper represents the first-in-human experience regarding the extraction of a Micra Transcatheter Pacing System.
Answers are grounded in this paper and cite their sources.
Supports feasibility of Micra extraction; hypothesis-generating and should not yet change practice.
Clinical trials investigating the safety and effectiveness of transcatheter leadless pacemakers in humans are ongoing.1,2 These devices offer the benefits of cardiac pacing with the potential for a significant decrease in many of the risks associated with conventional pacing systems, including hematoma formation, pneumothorax, lead-related complications, and vascular obstruction.3
No takes yet. Share an insight, caveat, or question.
Karim et al. (2015) studied this question. The first-in-human extraction of a Micra transcatheter pacing system was reported for a device class that potentially decreases risks associated with conventional pacing systems.
Synapse has enriched 10 related papers. Consider them for comparative context: